The PI3K Pathway in Human Disease

Jonathan M. Backer, The Regulation of Class IA PI 3-Kinases by Inter-Subunit Interactions Current Topics in Microbiology and Immunology. ,vol. 346, pp. 87- 114 ,(2010) , 10.1007/82_2010_52

Hong Liu, Derek C. Radisky, Dun Yang, Ren Xu, Evette S. Radisky, Mina J. Bissell, J. Michael Bishop, MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits Nature Cell Biology. ,vol. 14, pp. 567- 574 ,(2012) , 10.1038/NCB2491

Yasuo Terauchi, Youki Tsuji, Shinobu Satoh, Hideaki Minoura, Koji Murakami, Akira Okuno, Kouichi Inukai, Tomoichiro Asano, Yasushi Kaburagi, Kohjiro Ueki, Hiromu Nakajima, Toshiaki Hanafusa, Yuji Matsuzawa, Hisahiko Sekihara, Yuxin Yin, J. Carl Barrett, Hideaki Oda, Takatoshi Ishikawa, Yasuo Akanuma, Issei Komuro, Misao Suzuki, Ken-ichi Yamamura, Tatsuhiko Kodama, Harumi Suzuki, Shigeo Koyasu, Shinichi Aizawa, Kazuyuki Tobe, Yasuhisa Fukui, Yoshio Yazaki, Takashi Kadowaki, Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase Nature Genetics. ,vol. 21, pp. 230- 235 ,(1999) , 10.1038/6023

Daniel T. Patton, Oliver A. Garden, Wayne P. Pearce, Louise E. Clough, Clare R. Monk, Eva Leung, Wendy C. Rowan, Sara Sancho, Lucy S. K. Walker, Bart Vanhaesebroeck, Klaus Okkenhaug, Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells Journal of Immunology. ,vol. 177, pp. 6598- 6602 ,(2006) , 10.4049/JIMMUNOL.177.10.6598

Lucy R Yates, Moritz Gerstung, Stian Knappskog, Christine Desmedt, Gunes Gundem, Peter Van Loo, Turid Aas, Ludmil B Alexandrov, Denis Larsimont, Helen Davies, Yilong Li, Young Seok Ju, Manasa Ramakrishna, Hans Kristian Haugland, Peer Kaare Lilleng, Serena Nik-Zainal, Stuart McLaren, Adam Butler, Sancha Martin, Dominic Glodzik, Andrew Menzies, Keiran Raine, Jonathan Hinton, David Jones, Laura J Mudie, Bing Jiang, Delphine Vincent, April Greene-Colozzi, Pierre-Yves Adnet, Aquila Fatima, Marion Maetens, Michail Ignatiadis, Michael R Stratton, Christos Sotiriou, Andrea L Richardson, Per Eystein Lønning, David C Wedge, Peter J Campbell, None, Subclonal diversification of primary breast cancer revealed by multiregion sequencing Nature Medicine. ,vol. 21, pp. 751- 759 ,(2015) , 10.1038/NM.3886

Klaus Okkenhaug, Daniel T. Patton, Antonio Bilancio, Fabien Garçon, Wendy C. Rowan, Bart Vanhaesebroeck, The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells Journal of Immunology. ,vol. 177, pp. 5122- 5128 ,(2006) , 10.4049/JIMMUNOL.177.8.5122

David A. Fruman, Franck Mauvais-Jarvis, Daniel A. Pollard, Claudine M. Yballe, Derek Brazil, Roderick T. Bronson, C. Ronald Kahn, Lewis C. Cantley, Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nature Genetics. ,vol. 26, pp. 379- 382 ,(2000) , 10.1038/81715

Javier Munoz, Razelle Kurzrock, Targeted therapy in rare cancers--adopting the orphans. Nature Reviews Clinical Oncology. ,vol. 9, pp. 631- 642 ,(2012) , 10.1038/NRCLINONC.2012.160

Teeru Bihani, Scott A. Ezell, Brendon Ladd, Shaun E. Grosskurth, Anne Marie Mazzola, Mark Pietras, Corinne Reimer, Michael Zinda, Stephen Fawell, Celina M. D’Cruz, Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers. Oncotarget. ,vol. 6, pp. 2407- 2420 ,(2015) , 10.18632/ONCOTARGET.2964

Johanna C. Bendell, Robin K. Kelley, Kent C. Shih, Jennifer A. Grabowsky, Emily Bergsland, Suzanne Jones, Thomas Martin, Jeffrey R. Infante, Paul S. Mischel, Tomoo Matsutani, Shuichan Xu, Lilly Wong, Yong Liu, Xiaoling Wu, Deborah S. Mortensen, Rajesh Chopra, Kristen Hege, Pamela N. Munster, A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma Cancer. ,vol. 121, pp. 3481- 3490 ,(2015) , 10.1002/CNCR.29422